BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37625844)

  • 1. Linkage of Blood MALT1 with CD4+ T Cell Subset, Inflammation, Lipid, and Its Potency as a Biomarker for Predicting Major Adverse Cardiovascular Events in Coronary Heart Disease Patients.
    Zhang L; Li J; Yang Z; Wang S; Liu J; Luan S; Tian G
    Ann Clin Lab Sci; 2023 Jul; 53(4):507-515. PubMed ID: 37625844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum brain-derived neurotrophic factor in coronary heart disease: Correlation with the T helper (Th)1/Th2 ratio, Th17/regulatory T (Treg) ratio, and major adverse cardiovascular events.
    Huo Y; Feng Q; Fan J; Huang J; Zhu Y; Wu Y; Hou A; Zhu L
    J Clin Lab Anal; 2023 Jan; 37(1):e24803. PubMed ID: 36510348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant blood MALT1 and its relevance with multiple organic dysfunctions, T helper cells, inflammation, and mortality risk of sepsis patients.
    Wang Y; Huang Q; He F
    J Clin Lab Anal; 2022 Apr; 36(4):e24331. PubMed ID: 35262976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MALT1 positively relates to Th17 cells, inflammation/activity degree, and its decrement along with treatment reflects TNF inhibitor response in ankylosing spondylitis patients.
    Yuan J; Xiang L; Wang F; Zhang L; Liu G; Chang X; Zhang A; Tao Y
    J Clin Lab Anal; 2022 Jul; 36(7):e24472. PubMed ID: 35622982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MALT1 Positively Relates to T Helper 1 and T Helper 17 cells, and Serves as a Potential Biomarker for Predicting 30-Day Mortality in Stanford Type A Aortic Dissection Patients.
    Zong J; Yang L; Wei L; Wang D; Wang X; Zhang Z
    Tohoku J Exp Med; 2023 Dec; 261(4):299-307. PubMed ID: 37704417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MALT1 regulates Th2 and Th17 differentiation
    Wang Q; Wang Y; Liu Q; Chu Y; Mi R; Jiang F; Zhao J; Hu K; Luo R; Feng Y; Lee H; Zhou D; Mi J; Deng R
    Front Immunol; 2022; 13():913830. PubMed ID: 35967391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation of circulating cell division cycle 42 expression with Th1, Th2, and Th17 cells, adhesion molecules, and biochemical indexes in coronary heart disease patients.
    Zhou M; Wu J; Tan G
    Ir J Med Sci; 2022 Oct; 191(5):2085-2090. PubMed ID: 34811660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of long non-coding RNA KCNQ1OT1 in estimating the stenosis, lipid level, inflammation status, and prognostication in coronary heart disease patients.
    Zhu L; Feng Q; Fan J; Huang J; Zhu Y; Wu Y; Hou A; Huo Y
    J Clin Lab Anal; 2023 Jan; 37(1):e24775. PubMed ID: 36458365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum YKL-40 in coronary heart disease: linkage with inflammatory cytokines, artery stenosis, and optimal cut-off value for estimating major adverse cardiovascular events.
    Song M; Zhang G; Shi H; Zhu E; Deng L; Shen H
    Front Cardiovasc Med; 2023; 10():1242339. PubMed ID: 38028459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical role of serum cell division control 42 in coronary heart disease.
    Feng Q; Guo J; Hou A; Guo Z; Zhang Y; Guo Y; Liu S; Cheng Z; Sun L; Meng L; Han S
    Scand J Clin Lab Invest; 2023 Feb; 83(1):45-50. PubMed ID: 36650947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MALT1 positively correlates with Th1 cells, Th17 cells, and their secreted cytokines and also relates to disease risk, severity, and prognosis of acute ischemic stroke.
    Chen X; Zhang X; Lan L; Xu G; Li Y; Huang S
    J Clin Lab Anal; 2021 Sep; 35(9):e23903. PubMed ID: 34273195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MALT1 in asthma children: A potential biomarker for monitoring exacerbation risk and Th1/Th2 imbalance-mediated inflammation.
    Liu L; Gao Y; Si Y; Liu B; Liu X; Li G; Wang R
    J Clin Lab Anal; 2022 May; 36(5):e24379. PubMed ID: 35353938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased long non-coding RNA NORAD reflects serious cardiovascular stenosis, aggravated inflammation status, and higher lipid level in coronary heart disease.
    Zhang X; Kan X; Shen J; Li J
    J Clin Lab Anal; 2022 Nov; 36(11):e24717. PubMed ID: 36319574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood MALT1 deficiency is common and relates to unfavorable induction therapy response and survival profile in acute myeloid leukemia patients.
    Geng H; Wang Y; Wang S
    Hematology; 2022 Dec; 27(1):1176-1183. PubMed ID: 36314929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood MALT1, Th1, and Th17 cells are dysregulated, inter-correlated, and correlated with disease activity in rheumatoid arthritis patients; meanwhile, MALT1 decline during therapy relates to treatment outcome.
    Ye Z; Chen L; Fang Y; Zhao L
    J Clin Lab Anal; 2022 Jan; 36(1):e24112. PubMed ID: 34788483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosa-associated lymphoid tissue lymphoma translocation protein 1 exaggerates multiple organ injury, inflammation, and immune cell imbalance by activating the NF-κB pathway in sepsis.
    Wang Y; Liu Z; Zhang M; Yu B; Ai F
    Front Microbiol; 2023; 14():1117285. PubMed ID: 36960276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Exosomal MicroRNA-186-5p Positively Correlates with Lipid Indexes, Coronary Stenosis Degree, and Major Adverse Cardiovascular Events in Coronary Heart Disease.
    Ren L; Liu W; Chen S; Zeng H
    Tohoku J Exp Med; 2024 Feb; 262(2):97-103. PubMed ID: 38057119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MALT1 reflects inflammatory cytokines, disease activity, and its chronological change could estimate treatment response to infliximab in Crohn's disease patients.
    Dong X; Chen X; Ren Y
    J Clin Lab Anal; 2022 Oct; 36(10):e24650. PubMed ID: 36036788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosa-associated lymphoid tissue lymphoma translocation protein 1 in rheumatoid arthritis: Longitudinal change after treatment and correlation with treatment efficacy of tumor necrosis factor inhibitors.
    Wang F; Liu G; Xiang L; Yuan J; Tao Y; Zhang L; Zhang A; Chang X
    J Clin Lab Anal; 2022 Jun; 36(6):e24449. PubMed ID: 35500150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of MALT1 as a candidate biomarker of disease surveillance and treatment response prediction in inflammatory bowel disease patients.
    Wu Z; Bi Y
    J Clin Lab Anal; 2022 Feb; 36(2):e24130. PubMed ID: 34997981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.